Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: A nationwide longitudinal study

Transplant International

Volumn 24, Issue 6, 2011, Pages 582-587

  Jacquet, Antoine ^a   Pallet, Nicolas ^b   Kessler, Michèle ^c   Hourmant, Maryvonne ^d   Garrigue, Valérie ^e   Rostaing, Lionel ^f   Kreis, Henri ^b   Legendre, Christophe ^b   Mamzer Bruneel, Marie France ^b  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CHU NANCY BRABOIS   (France)

^d HÔTEL DIEU   (France)

^e LAPEYRONIE HOSPITAL   (France)

^f CHU RANGUEIL   (France)

Author keywords

allograft survival; autosomic dominant polycystic kidney disease; renal transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; HYPERTENSION; INFECTION COMPLICATION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTICENTER STUDY; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; FRANCE; GRAFT SURVIVAL; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PULMONARY EMBOLISM; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 79955562823     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01237.x     Document Type: Article

References (22)

1. Gabow PA,. Autosomal dominant polycystic kidney disease. N Engl J Med 1993; 329: 332.
2. Simon P,. An epidemiologic approach for the prevention of renal insufficiency. Nephrologie 1996; 17: 283.
3. Andreoni KA, Pelletier RP, Elkhammas EA, et al. Increased incidence of gastrointestinal surgical complications in renal transplant recipients with polycystic kidney disease. Transplantation 1999; 67: 262.
4. Fitzpatrick PM, Torres VE, Charboneau JW, Offord KP, Holley KE, Zincke H,. Long-term outcome of renal transplantation in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1990; 15: 535.
5. Stiasny B, Ziebell D, Graf S, Hauser IA, Schulze BD,. Clinical aspects of renal transplantation in polycystic kidney disease. Clin Nephrol 2002; 58: 16.
6. Ducloux D, Motte G, Vautrin P, Bresson-Vautrin C, Rebibou JM, Chalopin JM,. Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus. Nephrol Dial Transplant 1999; 14: 1244.
7. Florijn KW, Chang PC, van der Woude FJ, van Bockel JH, van Saase JL,. Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation. Transplantation 1994; 57: 73.
8. Hamer RA, Chow CL, Ong AC, McKane WS,. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007; 83: 36.
9. Johnston O, O'Kelly P, Donohue J, et al. Favorable graft survival in renal transplant recipients with polycystic kidney disease. Ren Fail 2005; 27: 309.
10. Knispel HH, Klan R, Offermann G, Miller K,. Transplantation in autosomal dominant polycystic kidney disease without nephrectomy. Urol Int 1996; 56: 75.
11. Sanfilippo FP, Vaughn WK, Peters TG, Bollinger RR, Spees EK,. Transplantation for polycystic kidney disease. Transplantation 1983; 36: 54.
12. Bretagnol A, Halimi JM, Roland M, et al. Autosomal dominant polycystic kidney disease: risk factor for nonmelanoma skin cancer following kidney transplantation. Transpl Int 2010; 23: 878.
13. Gladman DD, Farewell VT,. Longitudinal cohort studies. J Rheumatol Suppl 2005; 72: 30.
14. Gladman DD, Menter A,. Introduction/overview on clinical registries. Ann Rheum Dis 2005; 64 (Suppl. 2): ii101.
15. Khan NF, Harrison SE, Rose PW,. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010; 60: e128.
16. Najafian B, Kasiske BL,. Chronic allograft nephropathy. Curr Opin Nephrol Hypertens 2008; 17: 149.
17. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527.
18. Guirguis NG, Eicher C, Hock L, et al. Thromboembolic risk factors in patients undergoing kidney transplant: implication of abnormally short activated partial thromboplastin time. Ann Clin Lab Sci 2003; 33: 396.
19. de Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, Norman DJ,. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 2005; 67: 714.
20. Kelleher CL, McFann KK, Johnson AM, Schrier RW,. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. Am J Hypertens 2004; 17: 1029.
21. Hadimeri H, Norden G, Friman S, Nyberg G,. Autosomal dominant polycystic kidney disease in a kidney transplant population. Nephrol Dial Transplant 1997; 12: 1431.
22. Oliveras A, Roquer J, Puig JM, et al. Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome. Clin Transplant 2003; 17: 1.